Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.46), $0.01 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Investing.com’s stocks of the week